Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-27 09:40:42 - browse：48383

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Ohioans vote in high

WSS

Sage's campaign to raise awareness of postpartum depression hits a nerve

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Bristol Myers buys into radiopharmaceuticals with RayzeBio

In venture capital firm's success, lessons for turning crisis into profit

Astronauts get first look at the spacecraft that will fly them around the moon

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Hepatitis C has a cure — but many Americans still lack access to it

Bristol Myers buys into radiopharmaceuticals with RayzeBio

ChatGPT in medicine: STAT answers readers' burning questions

Wegovy cuts risk of cardiovascular events by 20%, study finds

Trump demands the U.S. pay no more for drugs than other countries … again

Carvykti CAR

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Trump demands the U.S. pay no more for drugs than other countries … again

Keeping primary care docs in field isn't impossible, says AAFP CEO

knowledge

How to keep neuroscience’s past racism from being its future

Wegovy cuts risk of cardiovascular events by 20%, study finds

Discs beat pads, tampons for heavy menstrual flow, new study shows

Astronauts get first look at the spacecraft that will fly them around the moon

Hospitals use virtual reality to design more inclusive rooms for kids

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

hotspot

explore

entertainment

knowledge